3
Announcements
Trials
Browse
Landscape
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Tumor-Agnostic
1
Conditions
Hodgkin Disease
29
Lymphoma
17
Lymphoma, Large B-Cell, Diffuse
6
Lymphoma, Follicular
4
Vulvar Neoplasms
3
Testicular Neoplasms
3
Neoplasms, Germ Cell and Embryonal
3
Lymphoma, Non-Hodgkin
3
Lymphoma, Large-Cell, Immunoblastic
3
Seminoma
2
Ovarian Neoplasms
2
Neoplasms
2
Dendritic Cell Sarcoma, Interdigitating
2
Breast Neoplasms
2
Warts
1
Ulcer
1
Testicular Germ Cell Tumor
1
Teratoma
1
Stomach Neoplasms
1
Skin Neoplasms
1
Recurrence
1
Rectal Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pathologic Processes
1
Ovarian Germ Cell Cancer
1
Neoplastic Processes
1
Neoplasms, Second Primary
1
Neoplasm Metastasis
1
Lymphoma, T-Cell, Peripheral
1
Lymphoma, Mantle-Cell
1
Interventions
Radiotherapy
2
Radiosurgery
2
Leucovorin
2
Irinotecan
2
Fluorouracil
2
Drug Therapy
2
sacubitril and valsartan sodium hydrate drug combination
1
icotinib
1
dostarlimab
1
beta Carotene
1
avelumab
1
alpha-Tocopherol
1
Varenicline
1
Tyrosine Kinase Inhibitors
1
Trastuzumab
1
Tobacco Use Cessation Devices
1
Therapeutics
1
Thalidomide
1
Temozolomide
1
Surveys and Questionnaires
1
Surgical Procedures, Operative
1
Semen Analysis
1
Registries
1
Probiotics
1
Patient Reported Outcome Measures
1
Panitumumab
1
Nicotine Chewing Gum
1
Myofascial Release Therapy
1
Megestrol Acetate
1
Isotretinoin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Neoplasms, Second Primary
×
Bleomycin
×
Clear all
NCT03199300
2025-12-11
InvestiCAT
University Medical Center Groningen
Active not recruiting
20 enrolled